Exosome Diagnostics, Inc. — Form D
Exosome Diagnostics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-06. The offering totals $30.3M, of which $30.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-06
- Form: D
- Accession: 0001491340-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.3M
- Amount sold: $30.3M
- Investors: 43
- Date of first sale: 2017-06-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-290040
Issuer
- Name: Exosome Diagnostics, Inc.
- CIK: 0001491340
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: Lasker Biomedical Research Building, NEW YORK, NY, 10032
- Phone: 646-339-3139
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| John Boyce | Director | New York, NY |
| Kapil Dhingra | Director | New York, NY |
| Peter Johann | Director | New York, NY |
| Geert-Jan HC Mulder | Director | Waltham, MA |
| Joseph Slattery | Director | Waltham, MA |
| Steven Soignet | Director | Waltham, MA |
| John Boyce | Executive Officer | New York, NY |
| William Kelly | Executive Officer | New York, NY |
| Thomas McLain | Executive Officer | Waltham, MA |
| Sara Barrington | Executive Officer | Westlake Village, CA |
| James McCullough | Director | New York, NY |
| James McCullough | Executive Officer | New York, NY |
| David Okrongly | Executive Officer | New York, NY |
| Thomas McLain | Director | Waltham, MA |
| Joseph Boystak | Director | New York, NY |
| Dhingra Kapil | Director | New York, NY |
| Wayne Comper | Executive Officer | New York, NY |
| Georg Nebgen | Director | New York, NY |
| Greg Zdechlik | Executive Officer | New York, NY |
Other filings by this issuer (8)
More